Pharmaceutical Fraud Initiative

Overview
In order to address the serious and growing problem of illicit online pharmaceutical sales, the FBI's National Cyber Forensics and Training Alliance (NCFTA) established the Pharmaceutical Fraud Initiative (PFI), in partnership with the Federal Bureau of Investigation’s Cyber Initiative and Resource Fusion Unit (CIRFU), and the Internet Crime Complaint Center (IC3). The purpose of this initiative is to provide a neutral forum wherein private industry and law enforcement can exchange information regarding emerging and ongoing threats to the pharmaceutical industry, while utilizing the NCFTA generated target/trend assessments to support risk mitigation pursuits. Given that the United States is clearly a targeted market for online pharmacies, the primary objective of the Initiative is to identify criminal actors and organizations that are engaging in pharmaceutical fraud. Analysis is aimed at presenting these targets to private industry for prospective law enforcement action and civil mitigation.